Recombinant Human Erythropoietin in the Treatment of Cancer-Related Anaemia
- 1 January 1994
- journal article
- research article
- Published by S. Karger AG in Oncology
- Vol. 51 (6) , 497-501
- https://doi.org/10.1159/000227392
Abstract
The aim of this study was to investigate the effects of recombinant human erythropoietin (rh-EPO) in patients with cancer-related anaemia. Thirty-six ambulatory patients who had malignant neoplasms and haemoglobin (Hb) values ofKeywords
This publication has 0 references indexed in Scilit: